| DESCRIPTION |
NOTE: The beta-blockers/related subclassification (CV100)
subclassification.
includes all single-entity beta-blockers and alpha-beta-
blockers. Combinations containing a beta-blocker are
included with the combination antihypertensives (CV400).
The alpha-blockers/related subclassification (CV150)
includes both peripheral and central single-entity
products. All antihypertensive combinations, with the
exception of potassium-sparing diuretics in combination
with other diuretics (CV704), are included in the CV400
|
